Q3 FY2026 Quarterly Result Highlights of Bajaj Housing Finance, DMart, AWFIS, DAM Capital, Hexaware Tech, Indegene, and Lal PathLabs

Awfis Space Solutions (AWFIS) Q3 Results 2026 Highlights: Revenue Up 20%, PAT up 43%

• Net Profit: Jumped 43% YoY to ₹21.65 crore, up from ₹15.17 crore in the same quarter last year.
• Revenue: Rose 20% YoY to ₹381.7 crore, driven by strong demand in the coworking segment.
• EBITDA: Increased 30% YoY to ₹139 crore, with margins expanding to 36%.
• Operational Growth: Added 10 new centers, bringing the total to 257 centers and ~1.77 lakh seats
• Stock Verdict: Neutral

Bajaj Housing Finance Q3 FY2026 Results Highlights: Profit Up 21%

• Net Profit: Grew 21% YoY to ₹665 crore.
• NII: Net Interest Income (NII) grew 19% YoY to ₹963 crore.
• AUM: Assets Under Management (AUM) reached ₹1,33,412 crore, a 23% increase YoY.
• Asset Quality: Gross NPA stood at 0.27%, while Net NPA was 0.11%
• Stock Verdict: Positive

DAM Capital Q3 FY2026 Result: PAT Down 61% & Income Falls 33% YoY

• DAM Capital Q3 FY26 PAT Down 61% to ₹20 Cr; Income Falls 33% YoY
• Net profit of DAM Capital declined 61.5 per cent to ₹20.06 crore in the quarter ended December 2025, compared with ₹51.51 crore in the corresponding quarter last year.
• Revenue from operations fell 32.74 per cent to ₹69.94 crore during the quarter, as against ₹103.98 crore in the year-ago period. 
• During the Q3FY26, the company executed five transactions, including two initial public offerings (IPOs), one qualified institutional placement (QIP), one rights issue and one mergers and acquisitions advisory transaction. It raised around ₹4,376 crore during the quarter through equity capital markets transactions.
• The company achieved a 12 per cent market share in IPOs by number, executing 11 of the 94 IPOs during the nine months ended FY26.
• 22 IPOs are currently in the pipeline, with three new IPO mandates added during Q3FY26, indicating sustained client traction.
• In terms of operational highlights, DAM Capital executed 5 transactions in Q3 FY26, including 2 IPOs, 1 QIP, 1 Rights Issue, and 1 M&A advisory transaction, raising approximately ₹4,376 crore.
• The company has executed 96 ECM transactions since November 2019 and maintains a robust IPO pipeline of 22 mandates. Revenue from Merchant Banking was ₹48.5 crore for the quarter, and revenue from Broking Services was ₹17.6 crore.
• Stock Verdict: Negative

DMart Q3 FY2026 Results: Profit up 18%

• DMart reported an 18.3% rise in net profit in Q3 FY26
• Revenue crossed ₹18,100 crore, driven by steady store level growth
• Operating efficiency and cost control supported margins
• Consumer demand remained resilient despite inflation pressures
• Results reinforced DMart’s long term retail growth story.
• The consolidated PAT (Profit After Tax) margin stood at 4.73% in Q3 FY26, compared to 4.53% in Q3 FY25. Total expenses for the quarter rose by approximately 13% to ₹16,942.62 crore, primarily driven by a surge in purchases of stock-in-trade.
• Consolidated EBITDA of ₹1,462.56 crore for the December quarter, a 20% increase over the ₹1,217.43 crore reported in Q3 FY25.
• Basic earnings per share (EPS) for the quarter stood at ₹13.15, up from ₹11.12 a year ago.
• The Mumbai-based retailer added ten new stores during the December quarter, pushing its total count to 442 stores across India.
• A key highlight of the quarter was a revival in growth from older stores. “Our revenue for the quarter grew by 13.2%. Profit after tax (PAT) grew by 17.6% over the previous year. Two-year-old DMart stores grew by 5.6% in Q3 FY26 as compared to Q3 FY25,” said Anshul Asawa, chief executive officer (CEO) of the company.
• Food and grocery products continued to dominate the retailer’s sales mix, contributing 57.19% of total revenue. General merchandise and apparel accounted for 22.98%, while non-food FMCG contributed 19.83%.
• Stock Verdict: Positive

Hexaware Technologies Q3 FY2026 Result: Revenue up 10%

• Hexaware Technologies delivered mixed Q3FY26 results with strong operational performance highlighted by 22.4% EBITDA growth to ₹6 billion and margin expansion to 17.28% from 15.55% previous year.
• Revenue grew 10.5% to ₹34.8 billion, demonstrating business momentum, while net profit declined 9.4% to ₹2.9 billion, indicating non-operational headwinds affecting bottom-line performance.
• Company delivered strong operational performance with EBITDA surging 22.4% to ₹6.0 billion compared to ₹4.9 billion in the previous year.
• While EBITDA performance was robust, the company experienced a decline in consolidated net profit, which decreased to ₹2.9 billion from ₹3.2 billion in Q3 of the previous year. This 9.4% year-over-year decline suggests that non-operational factors or higher depreciation and interest costs impacted the final bottom-line performance.
• The Q3 results showcase Hexaware Technologies’ operational strength with significant improvements in core profitability metrics.
• The company successfully grew its top line by over 10% while achieving remarkable EBITDA growth of 22.4% and margin expansion, indicating effective cost optimization and business efficiency improvements during the reporting period
• Stock Verdict: Neutral

Indegene Q3 FY2026 Results: Revenue up 30%

• Indegene reported a robust revenue growth of 30.8% YoY and 17.1% QoQ
• The company achieved an adjusted EBITDA margin of 18.5%, marking a 30 basis points improvement quarter-on-quarter.
• Indegene secured seven large deals exceeding $1 million ACV each, showcasing strong new business generation.
• The company has successfully integrated BioPharm, with positive client responses and no disruption in active engagements.
• Indegene is leveraging AI and Gen AI to enhance productivity and expand its service offerings, positioning itself as a strategic partner in the life sciences industry.
• Stock Verdict: Positive

Dr. Lal PathLabs Q3 FY2026: Revenue up 10.6%

• Dr. Lal PathLabs Q3 FY2026 results showed a 10.6% YoY revenue increase to ₹660 crore, driven by 2.7% volume growth and strong performance from Swasthfit (26% of revenue).
• While EBITDA (before exceptional items) grew 16.3% to ₹179 crore (27.2% margin), net profit fell 6.4% to ₹91 crore due to a ₹30 crore one-time labor code expense. 
• Revenue: ₹660 Crore ((+10.6\%) YoY).
• EBITDA (Pre-exceptional): ₹179 Crore ((+16.3\%) YoY, 27.2% margin).
• PAT (Profit After Tax): ₹91 Crore ((-6.4\%) YoY, 13.9% margin). 
• Volume: Patient volumes grew 2.7% in Q3, with 4.4% year-to-date growth, despite a decline in seasonal fever testing.
• Growth Driver: Swasthfit (preventive health) contributes 26% of revenue, with particular strength in Tier 3/4 towns.
• Management confirmed a full-year organic revenue growth guidance of 11–12%
• Stock Verdict: Neutral